F Maechler1, C Geffers2, F Schwab2, L-A Peña Diaz2, M Behnke2, P Gastmeier2. 1. Institut für Hygiene und Umweltmedizin, Nationales Referenzzentrum für die Surveillance von Nosokomialen Infektionen, Charité Universitätsmedizin Berlin, Hindenburgdamm 27, 12203, Berlin, Deutschland. friederike.maechler@charite.de. 2. Institut für Hygiene und Umweltmedizin, Nationales Referenzzentrum für die Surveillance von Nosokomialen Infektionen, Charité Universitätsmedizin Berlin, Hindenburgdamm 27, 12203, Berlin, Deutschland.
Abstract
BACKGROUND: The frequency of multidrug-resistant organisms (MDRO) is increasing in Germany and worldwide. OBJECTIVES: Presentation of MDRO resistance rates and prevalence in Germany MATERIALS AND METHODS: Results from the Antibiotic Resistance Surveillance (ARS) and Hospital Infection Surveillance Systems (Krankenhausinfektions-Surveillance-Systems, KISS) and from recent prevalence surveys are presented. RESULTS: MRSA-resistance rates and the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) have remained at a stable level over the last few years. In contrast, vancomycin-resistant enterococci (VRE) and multidrug-resistant gramnegative (MRGN) bacteria have increased considerably. VRE prevalence has more than tripled in the past 5 years, and Escherichia coli resistant to third-generation cephalosporins, acylureidopenicillins, and fluoroquinolones increased by 43% in 2015 compared with the previous year. CONCLUSIONS: New policies to control MDRO should focus on VRE and the heterogeneous group of MRGN bacteria. In the case of the latter, the different bacterial species' characteristics should be taken into consideration.
BACKGROUND: The frequency of multidrug-resistant organisms (MDRO) is increasing in Germany and worldwide. OBJECTIVES: Presentation of MDRO resistance rates and prevalence in Germany MATERIALS AND METHODS: Results from the Antibiotic Resistance Surveillance (ARS) and Hospital Infection Surveillance Systems (Krankenhausinfektions-Surveillance-Systems, KISS) and from recent prevalence surveys are presented. RESULTS: MRSA-resistance rates and the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) have remained at a stable level over the last few years. In contrast, vancomycin-resistant enterococci (VRE) and multidrug-resistant gramnegative (MRGN) bacteria have increased considerably. VRE prevalence has more than tripled in the past 5 years, and Escherichia coli resistant to third-generation cephalosporins, acylureidopenicillins, and fluoroquinolones increased by 43% in 2015 compared with the previous year. CONCLUSIONS: New policies to control MDRO should focus on VRE and the heterogeneous group of MRGN bacteria. In the case of the latter, the different bacterial species' characteristics should be taken into consideration.
Authors: A Hamprecht; A M Rohde; M Behnke; S Feihl; P Gastmeier; F Gebhardt; W V Kern; J K Knobloch; A Mischnik; B Obermann; C Querbach; S Peter; C Schneider; W Schröder; F Schwab; E Tacconelli; M Wiese-Posselt; T Wille; M Willmann; H Seifert; J Zweigner Journal: J Antimicrob Chemother Date: 2016-06-17 Impact factor: 5.790
Authors: Jaishri Mehraj; Manas K Akmatov; Julia Strömpl; Anja Gatzemeier; Franziska Layer; Guido Werner; Dietmar H Pieper; Eva Medina; Wolfgang Witte; Frank Pessler; Gérard Krause Journal: PLoS One Date: 2014-09-24 Impact factor: 3.240
Authors: Silva Holtfreter; Dorothee Grumann; Veronika Balau; Annette Barwich; Julia Kolata; André Goehler; Stefan Weiss; Birte Holtfreter; Stephanie S Bauerfeind; Paula Döring; Erika Friebe; Nicole Haasler; Kristin Henselin; Katrin Kühn; Sophie Nowotny; Dörte Radke; Katrin Schulz; Sebastian R Schulz; Patricia Trübe; Chi Hai Vu; Birgit Walther; Susanne Westphal; Christiane Cuny; Wolfgang Witte; Henry Völzke; Hans Jörgen Grabe; Thomas Kocher; Ivo Steinmetz; Barbara M Bröker Journal: J Clin Microbiol Date: 2016-09-07 Impact factor: 5.948
Authors: Thomas von Lengerke; Ella Ebadi; Bettina Schock; Christian Krauth; Karin Lange; Jona T Stahmeyer; Iris F Chaberny Journal: Antimicrob Resist Infect Control Date: 2019-03-25 Impact factor: 4.887
Authors: Claudia Peters; Madeleine Dulon; Albert Nienhaus; Anja Schablon Journal: Int J Environ Res Public Health Date: 2019-06-04 Impact factor: 3.390
Authors: Franziska Hofmann; Ursel Heudorf; Katrin Steul; Thomas A Wichelhaus; Silke Besier; Michael Hogardt; Daniel Hack; Elvira Steinmann; Volkhard A J Kempf; Claudia Reinheimer Journal: GMS Hyg Infect Control Date: 2020-04-23